Home
Conditions
Gastric Adenocarcinoma

Clinical trial condition

Gastric Adenocarcinoma

Explore clinical trials studying Gastric Adenocarcinoma. Study availability and eligibility vary by location and protocol.

200 public trials 62 recruiting studies

Refine in advanced search Browse all conditions

Gastric Adenocarcinoma trial results

Not yet recruiting

Cadonilimab+ Paclitaxel (Albumin-bound) Treat Advanced Gastric Adenocarcinoma With PD-(L)1 Inhibitors Resistance

NCT06118645

Conditions: Gastric Adenocarcinoma
Locations: Not specified

View Trial Details

Enrolling by invitation

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence

NCT07139951

Conditions: Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, +5 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Enrolling by invitation

Luso-Cor Stent Compared to Other Endoscopic Techniques for Management of Fistulas and Anastomotic Dehiscences(ES-LCCE-UDFM)

NCT06862479

Conditions: Anastomotic Leak, Anastomotic Leak Esophagus, Body Weight, +28 more
Locations: Serviço de Gastrenterologia e Hepatologia, Unidade Local de Saúde Santa Maria Lisbon, Lisbon District, Portugal

View Trial Details

Enrolling by invitation

Laparoscopic Staging for Stage III Gastric Cancer

NCT07533825

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +7 more
Locations: Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, China

View Trial Details

Active, not recruiting

Compare Neoadjuvant DOS Combined With Toripalimab Versus SOX Combined With Toripalimab in Locally Advanced Gastric Adenocarcinoma

NCT03691454

Conditions: Gastric Adenocarcinoma
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Active, not recruiting

Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer

NCT03776487

Conditions: Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage I Gastric Cancer AJCC v8, +25 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

NCT04152499

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations: Los Angeles Hematology Oncology Medical Group Glendale, California, United States

University of California Los Angeles Los Angeles, California, United States

Florida Cancer Specialists and Research Institute Sarasota, Florida, United States

START MidWest Grand Rapids, Michigan, United States

View all 109 locations

View Trial Details

Active, not recruiting

ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma

NCT06206733

Conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Locations: Beijing cancer hospital Beijing, China

View Trial Details

Active, not recruiting

Iparomlimab and Tuvonralimab Injection (QL1706) Combined With DOS as Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction

NCT07776639

Conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Locations: The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China

View Trial Details

Active, not recruiting

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

NCT06399757

Conditions: Adenocarcinoma, Adenocarcinoma, Mucinous, Adnexal Diseases, +46 more
Locations: City of Hope Duarte, California, United States

City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States

Florida Cancer Specialists & Research Institute Sarasota, Florida, United States

University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Gastric Adenocarcinoma

Gastric Adenocarcinoma trial results

Related conditions